Product Reports Resources Pricing Login Book a demo

BZAM

Biotech & Life Sciences · Hamilton, Canada · Founded 2012 · IPO 2018

TGOD grows high quality, organic cannabis with sustainable, all-natural principles TGOD has a funded capacity of 116,000 kg MoreLess

The Green Organic Dutchman (TGOD) is a global leader in cultivating premium, certified organically grown cannabis. Operating in the cannabis industry, TGOD serves both medical and recreational cannabis users who prioritize organic and sustainable products. The company adheres to strict organic growing standards, utilizing living soil and avoiding synthetic fertilizers and chemicals to ensure high-quality, lab-tested cannabis. TGOD's business model focuses on producing and selling a wide range of cannabis products through various retail channels, including provincial retailers and medical partners. Revenue is generated through the sale of these premium cannabis products, which are marketed for their quality, consistency, and high potency. TGOD also emphasizes sustainability and community betterment, integrating these principles into their cultivation and business practices.

Keywords: organic cannabis, premium quality, living soil, sustainability, lab-tested, high potency, medical cannabis, recreational cannabis, retail channels, community betterment.

Valuation $97M
Revenue $50M
Total funding $50–100M

Company overview

BZAM company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2012
Headquarters
Hamilton, Canada
Employees
Open positions
None listed
Dealroom signal
56.5
Investment activity
4 companies · latest Dec 2023
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryPharmaceuticalsectorConsumer Goodsbusiness modelManufacturingindustryHealthsectorBiotechnologysectorCannabissectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

BZAM funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
PRIVATE PLACEMENT VCOther financing Oct 2023 $1.5M Clarus Securities
PRIVATE PLACEMENT VCOther financing May 2023 $3.7M Undisclosed
POST IPO DEBTDebt Sep 2021 $22M Undisclosed
POST IPO EQUITYOther financing Dec 2020 $9.3M Mackie Research Capital Corporation · Canaccord Genuity Wealth Limited
POST IPO DEBTDebt Apr 2020 $30M Undisclosed
POST IPO EQUITYOther financing Nov 2019 Undisclosed
POST IPO EQUITYOther financing Jun 2018 Undisclosed
IPOOther financing May 2018 Undisclosed
LATE VCOther financing Feb 2018 Aurora Cannabis
EARLY VCOther financing Sep 2017 Undisclosed
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue over time

Available revenue history. Fields without reported data are omitted.

YearRevenueGrowth
2026 $50M 0%
2025 $50M 0%
2024 $50M 0%
2023 $50M 0%
2022 $50M +127.5%
2021 $22M +2.9%
2020 $22M
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

BZAM website traffic

Latest recorded traffic for BZAM is 130 monthly website visits, down 94.3% over the last three months.

Latest monthly visits130 3-month web change-94.3%
Monthly website visits85 observations · Jun 2018–Jun 2025
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

BZAM compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

BZAM's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on BZAM's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 3 investors entered at this stage
Aurora Cannabis
Mackie Research Capital Corporation
Canaccord Genuity Wealth Limited
Other known 2 additional known investors
Clarus Securities
Altitude Investment Management

Global footprint

Where BZAM has talent and traffic

Workforce by country
🇨🇦 Canada · Hamilton HQ
Book a demo for the full country breakdown

In the news

Latest news about BZAM

Recent press, funding announcements, and product moves mentioning BZAM — open to read from the original sources.

See all news

Market sentiment

What the market is saying about BZAM

An AI-synthesized read of the highest-engagement posts about BZAM on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BZAM’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.